Post by
Kisu on Mar 16, 2016 12:21pm
Tribute Results??
So why was this earnings release of Pozen only and later Tribute not advertized from the start. I was under the impression that the release was to be for the combined companies. Nicely engineered buying op for those wishing to get into ARZ now that there is finally some volume on the TSX created by the implosion of the stock price. Will TRX earnings improve the outlook??
Comment by
kuatolives on Mar 16, 2016 12:31pm
I was wondering the same thing myself. You have to undesrstand that the vast majority of people in the world are complete morons. On the bright side, when they release Q1 numbers, WOW, look! They more than doubled their revenue! WOWeeeeee!!!
Comment by
snootchybootchy on Mar 16, 2016 2:12pm
I personally voted against the deal but in Mr. Harris' defence, there wasn't such strong market sentiment against spec pharma companies when he made the deal. And the share price more than doubled shortly after the merger announcement. I should have sold off some of my holdings then but that's on me, not Mr. Harris.
Comment by
GoldenDilemma on Mar 16, 2016 3:39pm
Yes, knee-jerk reactions and emotional sentiment will be the culprit for any investor. I am with you on this one - hold till the Yosprala party begings. I do believe 2016 may not be our year, but 2017 onwards for the gravy train.